NGL Fine Chem Hits Upper Circuit Amidst Unprecedented Buying Interest

Nov 20 2025 09:50 AM IST
share
Share Via
NGL Fine Chem Ltd has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and only buy orders queued on the exchange. This rare market phenomenon highlights intense demand and the absence of sellers, signalling a potential multi-day circuit scenario for the Pharmaceuticals & Biotechnology company.



On 20 Nov 2025, NGL Fine Chem Ltd, a player in the Pharmaceuticals & Biotechnology sector, demonstrated a remarkable trading pattern that has captured investor attention. The stock recorded a day performance gain of 1.81%, significantly outperforming the Sensex’s marginal rise of 0.12%. This surge is underscored by the fact that the stock’s order book shows exclusively buy orders, with no sellers willing to transact at current levels. Such a scenario is indicative of strong conviction among market participants and could lead to sustained price momentum in the near term.



Despite this intraday strength, the stock’s recent performance over longer time frames presents a more nuanced picture. Over the past week, NGL Fine Chem’s price has shown a decline of 3.23%, contrasting with the Sensex’s 0.95% gain. The one-month and three-month periods also reflect negative returns of 10.18% and 6.27% respectively, while the benchmark index advanced by 1.09% and 4.19% over the same durations. This divergence suggests that while the stock is currently experiencing a buying frenzy, it has faced headwinds in recent months.




Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!



  • - Clear entry/exit targets

  • - Target price revealed

  • - Detailed report available


View Target Price Report →




Examining the stock’s longer-term trajectory, NGL Fine Chem has underperformed the broader market significantly. The one-year return stands at -22.82%, while the Sensex recorded a 9.93% gain. Year-to-date figures show a similar trend, with the stock down 23.79% against the Sensex’s 9.15% rise. Over three years, the stock’s value declined by 23.48%, whereas the benchmark surged by 38.31%. Notably, the stock’s five-year and ten-year returns have remained flat at 0.00%, while the Sensex appreciated by 94.35% and 229.69% respectively. This long-term underperformance highlights the challenges faced by NGL Fine Chem in delivering shareholder value relative to the broader market.



From a technical standpoint, the stock’s price is positioned above its 200-day moving average, a level often viewed as a long-term support indicator. However, it remains below its 5-day, 20-day, 50-day, and 100-day moving averages, suggesting recent price resistance and a potential consolidation phase before the current buying interest. The upper circuit hit today, combined with the absence of sellers, may mark a turning point if sustained buying pressure continues.



The sector context is also relevant. The Pharmaceuticals & Biotechnology sector has experienced mixed performance in recent months, with some companies benefiting from innovation and regulatory approvals, while others face pricing pressures and supply chain challenges. NGL Fine Chem’s current market activity could reflect company-specific developments or speculative interest, but the lack of sellers at the upper circuit price is a clear sign of strong demand.




NGL Fine Chem or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!



  • - SwitchER analysis complete

  • - Superior alternatives found

  • - Multi-parameter evaluation


See Smarter Alternatives →




Investors monitoring NGL Fine Chem should note the extraordinary market dynamics at play. The upper circuit scenario, characterised by only buy orders and no sellers, is uncommon and may persist for multiple trading sessions if demand remains unabated. This could lead to further price appreciation in the short term, although the stock’s historical performance and technical indicators counsel caution.



Market participants may wish to analyse the underlying factors driving this surge, including any recent corporate announcements, sector developments, or broader market sentiment shifts. Given the stock’s past volatility and extended periods of underperformance relative to the Sensex, a comprehensive evaluation of fundamentals alongside technical signals is advisable before making investment decisions.



In summary, NGL Fine Chem’s current trading pattern reflects a strong buying interest that has propelled the stock to its upper circuit limit with no sellers in sight. While this indicates robust demand and potential for continued gains, the stock’s longer-term performance and technical positioning suggest that investors should remain vigilant and consider the broader market context.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News